Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vertex And Schering Hold Hep C Lead, But Others Look To Deal Themselves In

Apr 20 2009

• By The Pink Sheet

Related Content

Anadys/Novartis Hepatitis C Candidate Could Be Back In The Clinic By Year End

Feb 23 2007

Vertex Braces For HCV Combo Paradigm With ViroChem Buyout

Mar 04 2009

Wyeth Halts Alzheimer’s Trial, Drops HCV Candidate

Apr 17 2008

GSK Pays $34 Million Upfront To License Idenix’s Phase II HIV Candidate

Feb 06 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.